GI & Endoscopy

Researchers from Queen's University in Belfast, Ireland believe they've found a way to bypass bowel cancers defense against cetuximab, Science Daily reports.

American Gastroenterological Association Institute and North American Center for Continuing Medical Education have developed an educational presentation about inflammatory bowel disease, titled "Advancing IBD Practice in Our Communities."

Here are six updates on gastroenterology and endoscopy companies.

Residents of Montreal will have to wait longer for colonoscopies after Cliniques d'endoscopie du Quebec closed 11 private clinics throughout the province, CBCNews Montreal reports.

Laval, Canada-based Valeant Pharmaceuticals is entering a free fall, Business Insider reports.

Charles Barish, MD, is a gastroenterologist at Raleigh, N.C.-based Wake Gastroenterology.

A study in Cancer Medicine found that a new blood test is more sensitive than a standard carcinoembryonic antigen test when identifying colorectal cancer recurrence.

Peyton P. Berookim, MD, is a gastroenterologist and the director of the Los Angeles-based Gastroenterology Institute of Southern California.

Leverkusen, Germany-based Bayer submitted a new drug application to the FDA for Stivarga or Regorafenib, its second-line treatment for liver cancer patients, Tech Times reports.

Osaka, Japan-based Takeda Pharmaceuticals and New York City-based technology company Koneksa Health have partnered to integrate digital health tools into early-stage clinical trials.